Paper34859337
Population Pharmacokinetics of Melphalan in a Large Cohort of Autologous and Allogeneic Hematopoietic Cell Transplantation Recipients: Towards Individualized Dosing Regimens.
Shah GL and 13 others. Clin Pharmacokinet, 2022. Cited by 17 papers, by iCite.
Cite this record
ConductScience Library. Population Pharmacokinetics of Melphalan in a Large Cohort of Autologous and Allogeneic Hematopoietic Cell Transplantation Recipients: Towards Individualized Dosing Regimens. Papers, record 34859337. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/34859337
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics7
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Hematopoietic Stem Cell Transplantation | Major topic |
| Melphalan | Major topic |
| Adult | |
| Cohort Studies | |
| Humans | |
| Obesity | |
| Transplant Recipients |
Source PubMed
Grants4
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| P30 CA008748 | NCI NIH HHS | United States | P30CA008748 | PubMed and NIH | NIH RePORTER |
| UL1 TR001873 | NCATS NIH HHS | United States | UL1TR001873 | PubMed | NIH RePORTER |
| UL1 TR002384 | NCATS NIH HHS | United States | UL1TR002384 | PubMed | NIH RePORTER |
| P01 CA23766 | NIH HHS | United States | P01CA023766 | PubMed and NIH | NIH RePORTER |
References37
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 15255794 | What is the best size descriptor to use for pharmacokinetic studies in the obese? | Br J Clin Pharmacol | 2004 | https://conductscience.org/library/papers/15255794 | PubMed |
| 2 | 24662419 | Comparison of 1-day vs 2-day dosing of high-dose melphalan followed by autologous hematopoietic cell transplantation in patients with multiple myeloma. | Bone Marrow Transplant | 2014 | https://conductscience.org/library/papers/24662419 | PubMed |
| 3 | 11768292 | Ways to fit a PK model with some data below the quantification limit. | J Pharmacokinet Pharmacodyn | 2001 | https://conductscience.org/library/papers/11768292 | PubMed |
| 4 | 31376591 | Measurement of the DNA alkylating agents busulfan and melphalan in human plasma by mass spectrometry. | J Chromatogr B Analyt Technol Biomed Life Sci | 2019 | https://conductscience.org/library/papers/31376591 | PubMed |
| 5 | 31324638 | Fludarabine exposure in the conditioning prior to allogeneic hematopoietic cell transplantation predicts outcomes. | Blood Adv | 2019 | https://conductscience.org/library/papers/31324638 | PubMed |
| 6 | 19414839 | A new equation to estimate glomerular filtration rate. | Ann Intern Med | 2009 | https://conductscience.org/library/papers/19414839 | PubMed |
| 7 | 17324241 | Population pharmacokinetics of melphalan in paediatric blood or marrow transplant recipients. | Br J Clin Pharmacol | 2007 | https://conductscience.org/library/papers/17324241 | PubMed |
| 8 | 18066703 | Isolated limb perfusion with melphalan and TNF-alpha in the treatment of extremity sarcoma. | Curr Treat Options Oncol | 2007 | https://conductscience.org/library/papers/18066703 | PubMed |
| 9 | 16176118 | Quantification of lean bodyweight. | Clin Pharmacokinet | 2005 | https://conductscience.org/library/papers/16176118 | PubMed |
| 10 | 445964 | Kinetics of intravenous melphalan. | Clin Pharmacol Ther | 1979 | https://conductscience.org/library/papers/445964 | PubMed |
| 11 | 24914142 | Conditioning regimens for hematopoietic cell transplantation: one size does not fit all. | Blood | 2014 | https://conductscience.org/library/papers/24914142 | PubMed |
| 12 | 28160288 | Associations of High-Dose Melphalan Pharmacokinetics and Outcomes in the Setting of a Randomized Cryotherapy Trial. | Clin Pharmacol Ther | 2017 | https://conductscience.org/library/papers/28160288 | PubMed |
| 13 | 8649495 | A prospective, randomized trial of autologous bone marrow transplantation and chemotherapy in multiple myeloma. Intergroupe Français du Myélome. | N Engl J Med | 1996 | https://conductscience.org/library/papers/8649495 | PubMed |
| 14 | 498715 | Oral melphalan kinetics. | Clin Pharmacol Ther | 1979 | https://conductscience.org/library/papers/498715 | PubMed |
| 15 | 30471339 | Choosing a Reduced-Intensity Conditioning Regimen for Allogeneic Stem Cell Transplantation, Fludarabine/Busulfan versus Fludarabine Melphalan: A Systematic Review and Meta-Analysis. | Biol Blood Marrow Transplant | 2019 | https://conductscience.org/library/papers/30471339 | PubMed |
| 16 | 17914442 | Population pharmacokinetics of melphalan and glutathione S-transferase polymorphisms in relation to side effects. | Clin Pharmacol Ther | 2008 | https://conductscience.org/library/papers/17914442 | PubMed |
| 17 | 32609726 | Comparison of efficacy and toxicity of intravitreal melphalan formulations for retinoblastoma. | PLoS One | 2020 | https://conductscience.org/library/papers/32609726 | PubMed |
| 18 | 20956629 | Renal impairment in patients with multiple myeloma: a consensus statement on behalf of the International Myeloma Working Group. | J Clin Oncol | 2010 | https://conductscience.org/library/papers/20956629 | PubMed |
| 19 | 30390059 | Strategies to improve outcomes of autologous hematopoietic cell transplant in lymphoma. | Bone Marrow Transplant | 2019 | https://conductscience.org/library/papers/30390059 | PubMed |
| 20 | 28918602 | Population Pharmacokinetics and Optimal Sampling Strategy for Model-Based Precision Dosing of Melphalan in Patients Undergoing Hematopoietic Stem Cell Transplantation. | Clin Pharmacokinet | 2018 | https://conductscience.org/library/papers/28918602 | PubMed |
Cited by13
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 17 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42756177 | Toward adaptive therapeutic timing: integration of mechanistic pharmacology and artificial intelligence in precision dosing. | Front Pharmacol | 2026 | https://conductscience.org/library/papers/42756177 | PubMed |
| 42654041 | Accuracy of Real-Time PK-Guided Melphalan Dosing in Achieving Target Exposure in Myeloma Patients Undergoing Autologous Transplant. | Pharmaceutics | 2026 | https://conductscience.org/library/papers/42654041 | PubMed |
| 42418372 | Alternative conditioning regimens for hemoglobinopathy gene therapy: balancing efficacy, toxicity, and the next frontier. | Blood Adv | 2026 | https://conductscience.org/library/papers/42418372 | PubMed |
| 42174044 | Updated EBMT/ESID inborn errors working party guidelines for haematopoietic stem cell transplantation for inborn errors of immunity and metabolism. | Bone Marrow Transplant | 2026 | https://conductscience.org/library/papers/42174044 | PubMed |
| 42053946 | Population Pharmacokinetics of Melphalan in Pediatric Patients Undergoing Autologous Hematopoietic Stem Cell Transplantation with Various Conditioning Regimens. | Eur J Drug Metab Pharmacokinet | 2026 | https://conductscience.org/library/papers/42053946 | PubMed |
| 40616382 | Precision transplant and cell therapies for non-malignant disorders-The path forward. | Br J Haematol | 2025 | https://conductscience.org/library/papers/40616382 | PubMed |
| 40214172 | The Impact of Melphalan Conditioning and CD34 + Cell Dose and Schedule on Post-Transplant Outcomes in AL Amyloidosis. | Am J Hematol | 2025 | https://conductscience.org/library/papers/40214172 | PubMed |
| 40185404 | High Melphalan Exposure Increases the Risk of Graft-Versus-Host Disease in Pediatric Patients Undergoing Alpha-Beta T-Cell Depleted Haploidentical Transplantation. | Transplant Cell Ther | 2025 | https://conductscience.org/library/papers/40185404 | PubMed |
| 39602148 | Model-based dosing for better survival after transplantation. | Blood Adv | 2024 | https://conductscience.org/library/papers/39602148 | PubMed |
| 39343716 | Influence of Obesity on the Efficacy and Toxicity of Patients Undergoing Autologous Hematopoietic Cell Transplantation for Lymphoma. | Clin Lymphoma Myeloma Leuk | 2025 | https://conductscience.org/library/papers/39343716 | PubMed |
| 38097487 | Optimizing high dose melphalan. | Blood Rev | 2024 | https://conductscience.org/library/papers/38097487 | PubMed |
| 37379285 | Association between busulfan exposure and survival in patients undergoing a CD34+ selected stem cell transplantation. | Blood Adv | 2023 | https://conductscience.org/library/papers/37379285 | PubMed |
| 35545213 | Evaluation of Melphalan Exposure in Lymphoma Patients Undergoing BEAM and Autologous Hematopoietic Cell Transplantation. | Transplant Cell Ther | 2022 | https://conductscience.org/library/papers/35545213 | PubMed |
Genes2
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| ALB | 213 | PubTator's text mining | https://conductscience.org/library/genes/213 | NCBI Gene |
| SLC17A5 | 26503 | PubTator's text mining | https://conductscience.org/library/genes/26503 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/34859337
GET https://conductscience.org/api/papers/v1/34859337/references?page=2